share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券

美股sec公告 ·  02/26 10:30
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer, Sanna Bastiano, is set to sell 4,239 shares of common stock on 02/26/2024, with an aggregate market value of approximately $1,804,542. The shares to be sold were recently acquired on 02/24/2024, with 2,120 shares obtained through restricted stock vesting and 2,119 shares through performance shares, both as part of compensation from the issuer. This planned sale follows a three-month period where a total of 10,149 shares were sold by the officer, generating gross proceeds of around $4,266,460.
Vertex Pharmaceuticals Inc. officer, Sanna Bastiano, is set to sell 4,239 shares of common stock on 02/26/2024, with an aggregate market value of approximately $1,804,542. The shares to be sold were recently acquired on 02/24/2024, with 2,120 shares obtained through restricted stock vesting and 2,119 shares through performance shares, both as part of compensation from the issuer. This planned sale follows a three-month period where a total of 10,149 shares were sold by the officer, generating gross proceeds of around $4,266,460.
Vertex Pharmicals Inc.高管桑纳·巴斯蒂亚诺定于2024年2月26日出售4,239股普通股,总市值约为1,804,542美元。拟出售的股票最近于2024年2月24日被收购,其中2,120股通过限制性股票归属获得,2,119股通过绩效股票获得,均为发行人薪酬的一部分。此次计划出售是在三个月之后进行的,该官员共出售了10,149股股票,总收益约为4,266,460美元。
Vertex Pharmicals Inc.高管桑纳·巴斯蒂亚诺定于2024年2月26日出售4,239股普通股,总市值约为1,804,542美元。拟出售的股票最近于2024年2月24日被收购,其中2,120股通过限制性股票归属获得,2,119股通过绩效股票获得,均为发行人薪酬的一部分。此次计划出售是在三个月之后进行的,该官员共出售了10,149股股票,总收益约为4,266,460美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息